Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Poland's InPost to buy Yodel in £106m deal

(Sharecast News) - Poland's InPost said on Thursday that it has bought Yodel, one of the UK's largest parcel delivery companies, in a £106m deal. InPost said the deal further consolidates its "leading position" in the UK e-commerce delivery market.

"By combining the largest out-of-home (OOH) delivery network with Yodel's strong home delivery capabilities, InPost will scale its operations significantly, expand its service offering, and provide greater convenience to retailers and customers," it said.

As a result of the acquisition, InPost UK's market share will increase to around 8% and it will become the third-largest agnostic ecommerce logistics carrier in the UK.

Under the terms of the transaction, InPost has bought 95.5% of Judge Logistics' share capital, the parent company of Yodel, with PayPoint retaining a minority stake of 4.5%.

Rafał Brzoska, founder and chief executive of InPost, said: "This acquisition marks a pivotal milestone in InPost's journey to revolutionise the UK delivery market as well as the group pan-European presence.

"We have just fast-forwarded five years of organic expansion in the UK and it is a clear reflection of our long-term commitment to this market, a market where we see enormous opportunity for growth. Our logistics model has transformed delivery in other European markets, and with this acquisition, we are now well positioned to do the same here."

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.